Complement activation in animal and human pregnancies as a model for immunological recognition

Molecular Immunology

Volumn 48, Issue 14, 2011, Pages 1621-1630

  Girardi, Guillermina ^a   Prohászka, Zoltán ^b,c   Bulla, Roberta ^d   Tedesco, Francesco ^d   Scherjon, Sicco ^e,f  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d UNIVERSITY OF TRIESTE   (Italy)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Antibody dependent complement activation; Antiphospholipids (aPL); C1q; C3; Complement activation; Immune recognition; Placentation; Preeclampsia; Pregnancy; Pregnancy loss; T cells; Tissue factor; Trophoblast

Indexed keywords

COMPLEMENT COMPONENT C1Q;

COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; FETOPLACENTAL UNIT; FETUS; FETUS DISEASE; FETUS RISK; HUMAN; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REPRODUCTION; REVIEW; SPONTANEOUS ABORTION; SURVIVAL; T LYMPHOCYTE; TROPHOBLAST;

ABORTION, HABITUAL; ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; DISEASE MODELS, ANIMAL; FEMALE; FETAL GROWTH RETARDATION; HUMANS; MALE; MATERNAL-FETAL EXCHANGE; MICE; MODELS, IMMUNOLOGICAL; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; T-LYMPHOCYTES;

ANIMALIA; MAMMALIA;

EID: 79960471592     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.04.011     Document Type: Review

References (110)

1. Abrahams V.M., Mor G. Toll-like receptors and their role in the trophoblast. Placenta 2005, 26:540-547.
2. Adams K.M., Yan Z., Stevens A.M., Nelson J.L. The changing maternal " self" hypothesis: a mechanism for maternal tolerance of the fetus. Placenta 2007, 28:378-382.
3. Agostinis C., Bulla R., Tripodo C., Gismondi A., Stabile H., Bossi F., Guarnotta C., Garlanda C., De Seta F., Spessotto P., Santoni A., Ghebrehiwet B., Girardi G., Tedesco F. An alternative role of C1q in cell migration and tissue remodeling: contribution to trophoblast invasion and placental development. J. Immunol. 2010, 185:4420-4429.
4. Ahmed A. New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications. Thromb. Res. 2011, 127(Suppl. 3):S72-S75.
5. Ahmed A., Singh J., Khan Y., Seshan S.V., Girardi G. A new mouse model to explore therapies for preeclampsia. PLoS One 2010, 5:e13663.
6. Aluvihare V.R., Kallikourdis M., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 2004, 5:266-271.
7. Anthanassakis I., Vassiliadis S. Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: a paradigm in pregnancy. Immunology 2002, 107:281-287.
8. + regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J. Immunol. 2007, 178:2572-2578.
9. Atkinson J.P., Farries T.C. Separation of self from non-self in the complement system. Immunol. Today 1987, 8:212-215.
10. Babula O., Lazdane G., Kroica J., Ledger W.J., Witkin S.S. Relation between recurrent vulvovaginal candidiasis, vaginal concentrations of mannose-binding lectin, and a mannose-binding lectin gene polymorphism in Latvian women. Clin. Infect. Dis. 2003, 37:733-737.
11. Baldo A., Sniderman A.D., St-Luce S., Avramoglu R.K., Maslowska M., Hoang B., Monge J.C., Bell A., Mulay S., Cianflone K. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J. Clin. Invest. 1993, 92:1543-1547.
12. Baldwin W.M., Pruitt S.K., Brauer R.B., Daha M.R., Sanfilippo F. Complement in organ transplantation: contribution to inflammation, injury and rejection. Transplantation 1995, 59:797-808.
13. Bensa J.C., Reboul A., Colomb M.G. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes. Biochem. J. 1983, 216:385-392.
14. Billingham R.E., Medawar P.B. Actively acquired tolerance of foreign cells. Nature 1953, 172:603-606.
15. Bulla R., Villa A., Bossi F., Cassetti A., Radillo O., Spessotto P., De Seta F., Guaschino S., Tedesco F. VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. Exp. Cell Res. 2005, 303:101-113.
16. Bulla R., Agostinis C., Bossi F., Rizzi L., Debeus A., Tripodo C., Radillo O., De Seta F., Ghebrehiwet B., Tedesco F. Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium. Mol. Immunol. 2008, 45:2629-2640.
17. Bulla R., Bossi F., Agostinis C., Radillo O., Colombo F., De Seta F., Tedesco F. Complement production by trophoblast cells at the feto-maternal interface. J. Reprod. Immunol. 2009, 82:119-125.
18. Bulla R., De Seta F., Radillo O., Agostinis C., Durigutto P., Pellis V., De Santo D., Criovella S., Tedesco F. Mannose-binding lectin is produced by vaginal epithelial cells and its level in the vaginal fluid is influenced by progesterone. Mol. Immunol. 2010, 48:281-286.
19. Castellano G., Woltman A.M., Nauta A.J., Roos A., Trouw L.A., Seelen M.A., Schena F.P., Daha M.R., van Kooten C. Maturation of dendritic cells abrogates C1q production in vivo and in vitro. Blood 2004, 103:3813-3820.
20. Caucheteux S.M., Kanellopoulos-Langevin C., Ojcius D.M. At the innate frontiers between mother and fetus: linking abortion with complement activation. Immunity 2003, 18:169-172.
21. Celik N., Ozan H. Maternal serum mannose-binding lectin in severe preeclampsia. Clin. Exp. Obstet. Gynecol. 2008, 35:179-182.
22. Chaouat G., Dubanchet S., Ledee N. Cytokines: Important for implantation?. J. Assist. Reprod. Genet. 2007, 24:491-505.
23. Christiansen O.B., Nielsen H.S., Lund M., Steffensen R., Varming K. Mannose-binding lectin-2 genotypes and recurrent late pregnancy losses. Hum. Reprod. 2009, 24:291-299.
24. Clark D.A., Chaouat G., Arck P.C., Mittruecker H.W., Levy G.A. Cytokine-dependent abortion in CBA×DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase]. J. Immunol. 1998, 160:545-549.
25. Cohen D., Buurma A., Goemaere N.N., Girardi G., le Cessie S., Scherjon S., Bloemenkamp K.W.M., de Heer E., Bruijn J.A., Bajema I.M. Classical complement activation as a footprint for murine and human antiphospholipid antibody induced fetal loss. J. Pathol., 2011; 224; DOI: 10.1002/path.2893.
26. Csuka D., Molvarec A., Derzsy Z., Varga L., Fust G., Rigo J., Prohaszka Z. Functional analysis of the mannose-binding lectin complement pathway in normal pregnancy and preeclampsia. J. Reprod. Immunol. 2010, 87:90-96.
27. Cunningham D.S., Tichenor J.R. Decay-accelerating factor protects human trophoblast from complement-mediated attack. Clin. Immunol. Immunopathol. 1995, 74:156-161.
28. Damsky C.H., Fisher S.J. Trophoblast pseudo-vasculogenesis: faking it with endothelial adhesion receptors. Curr. Opin. Cell Biol. 1998, 10:660-666.
29. Dankers M.K.A., Roelen D.L., Korfage N., de Lange P., Witvliet M., Sandkuijl L., Doxiadis I.I.N., Claas F.H.J. Differential immunogenicity of paternal HLA Class I antigens in pregnant women. Hum. Immunol. 2003, 64:600-606.
30. Dekker G., Robillard P.Y. Pre-eclampsia: is the immune maladaptation hypothesis still standing? An epidemiological update. J. Reprod. Immunol. 2007, 76:8-16.
31. Derksen R.H., Khamashta M.A., Branch D.W. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum. 2004, 50:1028-1039.
32. Derzsy Z., Prohaszka Z., Rigo J., Fust G., Molvarec A. Activation of the complement system in normal pregnancy and preeclampsia. Mol. Immunol. 2010, 47:1500-1506.
33. Esmon C.T. The interactions between inflammation and coagulation. Br. J. Haematol. 2005, 131:417-430.
34. Feinberg B.B. Preeclampsia: the death of Goliath. Am. J. Reprod. Immunol. 2006, 55:84-98.
35. Feucht H.E., Felber E., Gokel M.J., Hillebrand G., Nattermann U., Brockmeyer C. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin. Exp. Immunol. 1991, 86:464-470.
36. Ghai R., Waters P., Roumenina L.T., Gadjeva M., Kojouharova M.S., Reid K.B., Sim R.B., Kishore U. C1q and its growing family. Immunobiology 2007, 212:253-266.
37. Girardi G., Salmon J.B. The role of complement in pregnancy and fetal loss. Autoimmunity 2003, 36:19-26.
38. Girardi G., Berman J., Redecha P., Spruce L., Thurman J.M., Kraus D., Hollmann T.J., Casali P., Caroll M.C., Wetsel R.A., Lambris J.D., Holers V.M., Salmon J.E. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J. Clin. Invest. 2003, 112:1644-1654.
39. Girardi G., Redecha P., Salmon J.E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat. Med. 2004, 10:1222-1226.
40. Girardi G., Yarilin D., Thurman J.M., Holers V.M., Salmon J.E. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J. Exp. Med. 2006, 203:2165-2175.
41. Guerin L.R., Prins J.R., Robertson S.A. Regulatory T-cells and immune tolerace in pregnancy: a new target for infertility treatment?. Hum. Reprod. Update 2009, 15:517-535.
42. Hedlund M., Stenqvist A.C., Nagaeva O., Kjellberg L., Wulff M., Baranov V., Mincheva-Nilsson L. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J. Immunol. 2009, 183:340-351.
43. Holmes C.H., Simpson K.L. Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship. Bailliere's Clin. Obst. Gyn. 1992, 6:439-459.
44. Holmes C.H., Simpson K.L., Wainwright S.D., Tate C.G., Houlihan J.M., Sawyer I.H., Rogers I.P., Spring F.A., Anstee D.J., Tanner M.J. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J. Immunol. 1990, 144:3099-3105.
45. Holmes C.H., Simpson K.L., Okada H., Okada N., Wainwright S.D., Purcell D.F., Houlihan J.M. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur. J. Immunol. 1992, 22:1579-1585.
46. Huang Y., Zhu X.-Y., Du M.-R., Li D.-J. Human trophoblast recruited T lymphocytes and monocytes into the decidua by secretion of chemokine CXCL16 and the interaction with CXCR6 in the first-trimester pregnancy. J. Immunol. 2008, 180:2367-2375.
47. Jin L.P., Chen Q.Y., Zhang T., Guo P.F., Li D.J. The CD4(+)CD25(bright) regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down regulated in human miscarriage. Clin. Immunol. 2009, 133:402-410.
48. Kallikourdis M., Betz A.G. Periodic accumulation of regulatory T cells in the uterus: preparation for the implantation of a semi-allogeneic fetus?. PLoS One 2007, 2:e382.
49. Lam C., Lim K.H., Karumanchi S.A. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 2005, 46:1077-1085.
50. Langer H.F., Chung K.J., Orlova V.V., Choi E.Y., Kaul S., Kruhlak M.J., Alatsatianos M., Deangelis R.A., Roche P.A., Magotti P., Li X., Economopoulou M., Rafail S., Lambris J.D., Chavakis T. Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 2010, 116:4395-4403.
51. Laudansk P., Lemancewicz A., Pierzynski P., Akerlund M., Laudanski T. Decreased serum levels of macrophage inflammatory chemokines-3β/CCL19 in preterm labor and delivery. Eur. J. Obstet. Gynecol. Reprod. Biol. 2006, 124:23-26.
52. Lazar L., Rigo J., Nagy B., Balogh K., Mako V., Cervenak L., Mezes M., Prohaszka Z., Molvarec A. Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia. BMC Med. Genet. 2009, 10:120.
53. Leber A., Teles A., Zenclussen A.C. Regulatory T cells and their role in pregnancy. Am. J. Reprod. Immunol. 2010, 63:445-459.
54. Loos M., Martin H., Petry F. The Biosynthesis of C1q, the Collagen-like and Fc-recognizing Molecule of the Complement System 1989, Behring Institute Mitteilungen, pp. 32-41.
55. Lyall F., Bulmer J.N., Duffie E., Cousins F., Theriault A., Robson S.C. Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction. Am. J. Pathol. 2001, 158:1713-1721.
56. Lynch A.M., Gibbs R.S., Murphy J.R., Byers T., Neville M.C., Giclas P.C., Salmon J.E., Van Hecke T.M., Holers V.M. Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am. J. Obstet. Gynecol. 2008, 199(354):e1-8.
57. Lynch A.M., Murphy J.R., Gibbs R.S., Levine R.J., Giclas P.C., Salmon J.E., Holers V.M. The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia. BJOG 2010, 117:456-462.
58. Lynch A.M., Gibbs R.S., Murphy J.R., Giclas P.C., Salmon J.E., Holers V.M. Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes. Obstet. Gynecol. 2011, 117:75-83.
59. Maslowska M., Vu H., Phelis S., Sniderman A.D., Rhode B.M., Blank D., Cianflone K. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur. J. Clin. Invest. 1999, 29:679-686.
60. Matsuo S., Ichida S., Takizawa H., Okada N., Baranyi L., Iguchi A., Morgan B.P., Okada H. In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats. J. Exp. Med. 1994, 180:1619-1627.
61. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., Libermann T.A., Morgan J.P., Sellke F.W., Stillman I.E., Epstein F.H., Sukhatme V.P., Karumanchi S.A. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 2003, 111:649-658.
62. Mellor A.L., Sivakumar J., Chandler P., Smith K., Molina H., Mao D., Munn D.H. .Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol. 2001, 2:64-88.
63. Moffett A., Hiby S.E. How Does the maternal immune system contribute to the development of pre-eclampsia?. Placenta 2007, 28(Suppl. A):S51-S56.
64. Moldenhauer L.M., Diener K.R., Thring D.M., Brown M.P., Hayball J.D., Robertson S.A. Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. J. Immunol. 2009, 182:8080-8093.
65. Morgan B.P., Holmes C.H. Immunology of reproduction: protecting the placenta. Curr. Biol. 2000, 10:R381-R383.
66. Muller W., Hanauske-Abel H., Loos M. Reversible inhibition of C1Q release from guinea pig macrophages by 2,2'-dipyridyl: Evidence for a posttranslational hydroxylation step in the biosynthesis of C1Q, a subcomponent of the first component of complement (C1). FEBS Lett. 1978, 90:218-222.
67. Nauta A.J., Trouw L.A., Daha M.R., Tijsma O., Nieuwland R., Schwaeble W.J., Gingras A.R., Mantovani A., Hack E.C., Roos A. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur. J. Immunol. 2002, 32:1726-1736.
68. Nayak A., Ferluga J., Tsolaki A.G., Kishore U. The non-classical functions of the classical complement pathway recognition subcomponent C1q. Immunol. Lett. 2010, 131:139-150.
69. Nishikawa K., Matsuo S., Okada N., Morgan B.P., Okada H. Local inflammation caused by a monoclonal antibody that blocks the function of the rat membrane inhibitor of C3 convertase. J. Immunol. 1996, 156:1182-1188.
70. Oger P., Bulla R., Tedesco F., Portier A., Dubanchet S., Bailly M., Wainer R., Chaouat G., Ledee N. Higher interleukin-18 and mannose-binding lectin are present in uterine lumen of patients with unexplained infertility. Reprod. Biomed. Online 2009, 19:591-598.
71. Pellis V., De Seta F., Crovella S., Bossi F., Bulla R., Guaschino S., Radillo O., Garred P., Tedesco F. Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina. Clin. Exp. Immunol. 2005, 139:120-126.
72. Petroff M.G., Perchellet A. B7 family molecules as regulators of the maternal immune system in pregnancy. Am. J. Reprod. Immunol. 2010, 63:506-519.
73. Pijnenborg R., Bland J.M., Robertson W.B., Dixon G., Brosens I. The pattern of interstitial trophoblastic invasion of the myometrium in early human pregnancy. Placenta 1981, 2:303-316.
74. Redecha P., Tilley R., Tencati M., Salmon J.E., Kirchhofer D., Mackman N., Girardi G. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood 2007, 110:2423-2431.
75. Redecha P., Franzke C.W., Ruf W., Mackman N., Girardi G. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J. Clin. Invest. 2008, 118:3453-3461.
76. Redecha P., van Rooijen N., Torry D., Girardi G. Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury. Blood 2009, 113:4101-4109.
77. 25 T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol. Reprod. 2009, 80:1036-1045.
78. Saleh J., Summers L.K., Cianflone K., Fielding B.A., Sniderman A.D., Frayn K.N. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J. Lipid Res. 1998, 39:884-891.
79. Satpathy H.K., Fleming A., Frey D., Barsoom M., Satpathy C., Khandalavala J. Maternal obesity and pregnancy. Postgrad. Med. 2008, 120:E01-9.
80. + T cell responses. J. Immunol. 2006, 177:7567-7578.
81. Schwaelbe W.J., Reid K.B. Does properdin crosslink the cellular and the humoral immune response?. Immunol Today 1999, 20:17-21.
82. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
83. Smith S.D., Dunk C.E., Aplin J.D., Harris L.K., Jones R.L. Evidence for immune cell involvement in decidual spiral artery remodelling in early human pregnancy. Am. J. Pathol. 2009, 174:1959-1971.
84. Sodowski K., Zwirska-Korczala K., Kuka D., Kukla M., Budziszewska P., Zebaty A., Wender-Ozegowska E., Baumert M., Wloch A. Acylation stimulating protein is associated with pregnancy weight gain. J. Physiol. Pharmacol. 2008, 59(Suppl. 4):33-43.
85. Solier C., Aguerre-Girr M., Lenfant F., Campan A., Berrebi A., Rebmann V., Grosse-Wilde H., Le Bouteiller P. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1. Eur. J. Immunol. 2002, 32:3576-3586.
86. Spessotto P., Bulla R., Danussi C., Radillo O., Cervi M., Monami G., Bossi F., Tedesco F., Doliana R., Colombatti A. EMILIN1 represents a major stromal element determining human trophoblast invasion of the uterine wall. J. Cell Sci. 2006, 119:4574-4584.
87. Steegers E.A., von Dadelszen P., Duvekot J.J., Pijnenborg R. Pre-eclampsia. Lancet 2010, 376:631-644.
88. Starzl T.E. Acquired immunologic tolerance: with particular reference to transplantation. Immunol Res. 2007, 38:6-41.
89. Tedesco F., Radillo O., Candussi G., Nazzaro A., Mollnes T.E., Pecorari D. Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae. Clin. Exp. Immunol. 1990, 80:236-240.
90. Tedesco F., Narchi G., Radillo O., Meri S., Ferrone S., Betterle C. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. J. Immunol. 1993, 151:1562-1570.
91. Than N.G., Romero R., Erez O., Kusanovic J.P., Tarca A.L., Edwin S.S., Kim J.S., Hassan S.S., Espinoza J., Mittal P., Mazaki-Tovi S., Friel L., Gotsch F., Vaisbuch E., Camacho N., Papp Z. A role for mannose-binding lectin, a component of the innate immune system in pre-eclampsia. Am. J. Reprod. Immunol. 2008, 60:333-345.
92. Thurman J.M., Kraus D.M., Girardi G., Hourcade D., Kang H.J., Royer P.A., Mitchell L.M., Giclas P., Salmon J., Gilkeson G., Holers V.M. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice. Mol. Immunol. 2005, 42:87-97.
93. Tilburgs T., van der Mast B.J., Nagtzaam N.M.A., Roelen D.L., Scherjon S.A., Claas F.H.J. Expression of NK cell receptors on decidual T cells in human. J. Reprod. Immunol. 2009, 80:22-32.
94. Tilburgs T., Scherjon S.A., van der Mast B.J., Haasnoot G.W., Versteeg-van der Voort-Maarschalk M., Roelen D.L., van Rood J.J., Claas F.H. Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J. Reprod. Immunol. 2009, 82:148-157.
95. Tilburgs T., Scherjon S.A., Roelen D.L., Claas F.H. Decidual CD8+CD28- T cells express CD103 but not perforin. Hum. Immunol. 2009, 70:96-100.
96. Tilburgs T., Claas F.H., Scherjon S.A. Elsevier trophoblast research award lecture: unique properties of decidual T cells and their role in immune regulation during human pregnancy. Placenta 2010, 31(Suppl.):S82-S86.
97. Tilburgs T., Schonkeren D., Eikmans M., Nagtzaam N.M., Datema G., Swings G.M., Prins F., van Lith J.M., van der Mast B.J., Roelen D.L., Scherjon S.A., Claas F.H. Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties. J. Immunol. 2010, 185:4470-4477.
98. van de Geijn F.E., Roos A., de Man Y.A., Laman J.D., de Groot C.J., Daha M.R., Hazes J.M., Dolhain R.J. Mannose-binding lectin levels during pregnancy: a longitudinal study. Hum. Reprod. 2007, 22:362-371.
99. van de Geijn F.E., Dolhain R.J., van Rijs W., Hazes J.M., de Groot C.J. Mannose-binding lectin genotypes and pre-eclampsia: a case-control study. Hum. Immunol. 2007, 68:888-893.
100. van Halteren A.G., Jankowska-Gan E., Joosten A., Blokland E., Pool J., Brand A., Burlingham W.J., Goulmy E. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood 2009, 114:2263-2272.
101. Wasowska B.A., Lee C.-Y., Halushka M.K., Baldwin W.M. New concepts of complement in allorecognition and graft rejection. Cell Immunol. 2007, 248:18-30.
102. Weir P.E. Immunofluorescent studies of the uteroplacental arteries in normal pregnancy. Br. J. Obstet. Gynaecol. 1981, 88:301-307.
103. Wells M., Bennett J., Bulmer J.N., Jackson P., Holgate C.S. Complement component deposition in uteroplacental (spiral) arteries in normal human pregnancy. J. Reprod. Immunol. 1987, 12:125-135.
104. Williams Z., Zepf D., Longtime J., Anchan R., Broadman B., Missmer S.A., Hornstein M. Foreign fetal cells persist in the maternal circulation. Fertl. Steril. 2008, 91:2593-2596.
105. Xu C., Mao D., Holers V.M., Palanca B., Cheng A., Molina H. A critical role for the murine complement regulator Crry in fetomaternal tolerance. Science 2000, 287:498-501.
106. Zavazava N., Hausmann R., Muller-Ruchholtz W. Inhibition of anti-HLAB7 alloreactive CTL by affinity purified soluble HLA. Transplantation 1991, 31:838-842.
107. Zenclussen M.L., Thuere C., Ahmad N., Wafula P.O., Fest S., Teles A., Leber A., Casalis P.A., Bechmann I., Priller J., Volk H.D., Zenclussen A.C. The persistence of paternal antigens in the maternal body is involved in regulatory T-cell expansion and fetal-maternal tolerance in murine pregnancy. Am. J. Reprod. Immunol. 2010, 63:200-208.
108. Zhong X.Y., Laivuori H., Livingston J.C., Ylikorkala O., Sibai B.M., Holzgreve W., Hahn S. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am. J. Obstet. Gynecol. 2001, 184:414-419.
109. Zhou Y., Fisher S.J., Janatpour M., Genbacev O., Dejana E., Wheelock M., Damsky C.H. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?. J. Clin. Invest. 1997, 99:2139-2151.
110. Zhou Y., Damsky C.H., Fisher S.J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?. J. Clin. Invest. 1997, 99:2152-2164.